secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001438133-24-000047
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA clears Tandem Mobi insulin pump for pediatric use ages 2+
-------------------------------------------------------------

- FDA cleared Tandem Mobi insulin pump for expanded pediatric indication in individuals two years and older.
- Clearance was granted via 510(k) application on March 21, 2024.
- Indication expansion broadens Tandem's addressable patient population beyond prior adult-only use.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000047/0001438133-24-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000047/tndm-20240321.htm
  HTML page:      https://secwatch.observer/filing/0001438133-24-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer